Student Name
Capella University
NURS-FPX 4060 Practicing in the Community to Improve Population Health
Prof. Name
Date
Health Promotion Plan
Hello, my name is ________, and I serve as a community nurse. I welcome you to today’s session, which focuses on Human Papillomavirus (HPV), a highly prevalent sexually transmitted infection. This session aims to provide an in-depth understanding of HPV, including its epidemiology, health impact, and a structured health promotion plan designed to enhance awareness, prevention, and patient outcomes.
Introduction to HPV
What is HPV?
Human Papillomavirus (HPV) is a diverse group of DNA viruses that predominantly infect epithelial cells of the skin and mucous membranes. To date, researchers have identified over 200 HPV types, with approximately 40 transmitted sexually (Soheili et al., 2021). High-risk types of HPV can infect the genital tract, oral cavity, and oropharyngeal region, leading to potential malignancies. HPV is the most common sexually transmitted infection globally, with nearly all sexually active individuals experiencing infection at some point in their lifetime (El-Zein et al., 2019).
Risk factors for HPV infection include multiple sexual partners, unprotected sexual encounters, polygamous relationships, men who have sex with men, and certain behavioral factors like substance use. Most infections are asymptomatic, often going unnoticed until complications such as genital warts or cancers manifest.
Why is awareness important?
HPV infections can remain dormant for years before presenting symptoms. While many infections resolve spontaneously, high-risk HPV types pose a significant threat, potentially causing cancers of the cervix, anus, oropharynx, and genital organs (WHO, 2023). Early awareness, routine screening, vaccination, and preventive practices are critical strategies to reduce morbidity and mortality associated with HPV.
Prevalence of HPV
Who is affected by HPV and how common is it?
HPV affects millions of individuals worldwide each year. In the United States alone, an estimated 42 million individuals were infected in 2018, with around 13 million new cases reported annually (HPV, 2023). Infection rates vary by age, gender, socioeconomic status, geography, and specific HPV types. Adolescents and young adults aged 15–25 are the most vulnerable, representing nearly 75% of new infections (Clarke et al., 2021).
How does prevalence differ between genders?
HPV affects both men and women, though manifestations vary. Women are primarily affected through cervical infections, which can progress to cervical cancer. In men, HPV is more likely to cause oropharyngeal cancers. Annually, approximately 21,000 women and 15,000 men are diagnosed with HPV-related complications, with around 4,000 female deaths reported (HPV, 2023).
What other factors influence prevalence?
| Factor | Observation |
|---|---|
| Socioeconomic Status | Individuals with middle- and low-income backgrounds experience higher HPV prevalence compared to high-income populations. |
| Geographic Location | Southern and Midwestern regions of the U.S. report higher infection rates than northern regions (Hirth et al., 2019). |
| Age | Teens and young adults (15–25 years) are most susceptible. |
| Gender | Women are more frequently infected, while men have a higher risk of HPV-associated throat cancers. |
Globally, cervical cancer ranks as the fourth leading cause of cancer-related deaths among women, resulting in approximately 342,000 deaths in 2020 (WHO, 2023). Oral HPV infection is estimated at 5.0% in men and 3.6% in women (Yu et al., 2023).
Impact of HPV
How does HPV affect health?
HPV infections can result in a wide spectrum of clinical outcomes. High-risk HPV types may cause cervical cancer, genital warts, and cancers of the vulva, vagina, penis, anus, mouth, and throat (Kombe et al., 2021).
The consequences extend beyond physical health. Psychologically, an HPV diagnosis may trigger anxiety, guilt, and social stress due to stigma (Chadwick et al., 2022). Socially, affected individuals may experience isolation or reduced support networks. Financially, the burden of screening, vaccination, and cancer treatment can be significant, particularly for economically disadvantaged populations (Chesson et al., 2021).
What strategies help reduce the impact?
Preventive measures include vaccination, public education, counseling, and access to community healthcare services. Nurses play a crucial role by educating patients, promoting routine screenings, and facilitating preventive care services (Luttjeboer et al., 2023).
Evidence-Based Health Promotion Plan
How can nurses contribute to HPV prevention?
Nurses and healthcare professionals are vital in promoting HPV awareness. Through workshops, pamphlets, and online platforms, educational strategies can dispel myths, increase knowledge of HPV risks, and encourage preventive behaviors (Rodríguez et al., 2019).
What community-based interventions are effective?
Schools and youth-focused organizations serve as key platforms for vaccination campaigns and sexual health education. Interventions such as counseling adolescents and parents, providing free screenings, and offering vaccinations through community clinics can prevent HPV-related cancers (Pathak et al., 2022; Bastani et al., 2021).
SMART Goals of Health Promotion Plan
What are the SMART goals for HPV prevention?
The SMART framework ensures goals are Specific, Measurable, Achievable, Relevant, and Time-bound (Bailey, 2019). Table 1 presents a tailored SMART plan for a patient, Maria, addressing her physical, emotional, social, and financial challenges.
| Goal | Description | Timeline |
|---|---|---|
| Reduce financial burden | Decrease healthcare expenses by 60% via awareness of insurance and assistance programs | 6 months |
| Increase HPV knowledge | Attend six in-person and virtual workshops to gain HPV-related knowledge | 3 months |
| Enhance social support | Join support groups to reduce stigma and social isolation | Ongoing |
| Improve emotional well-being | Participate in weekly therapy sessions to develop coping skills | 3 months |
Educational Outcomes of SMART Goals
Structured educational interventions can improve HPV literacy, reduce misconceptions, and empower patients. Maria’s participation in workshops and online support groups enhanced her understanding, facilitated access to preventive services, and improved emotional resilience. Therapy sessions further provided effective coping strategies for stress, depression, and anxiety (Santos et al., 2022).
How can educational sessions be improved?
| Improvement | Strategy |
|---|---|
| Cultural sensitivity | Tailor educational materials to diverse cultural backgrounds |
| Audience reach | Extend programs to schools, universities, and online platforms |
| Learning evaluation | Incorporate quizzes, polls, and discussion-based feedback |
| Multilingual resources | Provide materials in multiple languages to improve accessibility |
| Integration with healthcare | Collaborate with primary care providers for consistent messaging |
| Peer support | Include testimonials and experiences of individuals affected by HPV |
| Influencer engagement | Use social media and credible figures to promote preventive behaviors |
Healthy People 2030 Objectives and Leading Health Indicators
How does the plan align with national health objectives?
The Healthy People 2030 initiative aims for 90% HPV vaccination coverage among 15-year-old girls, 70% cervical cancer screening in women aged 35–45, and 90% treatment for HPV-related conditions (Vorsters et al., 2022; U.S. Department of Health and Human Services, 2023). Maria’s health plan aligns with these objectives by promoting preventive care, health literacy, and social support, with culturally tailored strategies addressing health inequities (Sundaram et al., 2019).
Health Policies to Achieve Established Goals
Which policies support HPV prevention?
Policies such as the Patient Protection and Affordable Care Act (ACA) provide coverage for preventive health services, ensuring equitable access (Raymond et al., 2021). Medicaid programs further support low- and middle-income populations in accessing screening and vaccination services. These policies complement community-based interventions, education, counseling, and therapy to optimize health outcomes.
Future Changes in Educational Sessions
How can educational sessions be enhanced?
Future improvements include:
- Expanding online workshops and integrating interactive tools like polls and quizzes.
- Providing multilingual and culturally sensitive materials.
- Incorporating peer support and testimonials to reduce stigma.
- Partnering with primary care professionals for consistent education.
- Engaging credible influencers to increase reach and effectiveness (Wong et al., 2020; Olusanya et al., 2021; Leung et al., 2019; Lewis et al., 2021).
Conclusion
HPV remains a common sexually transmitted infection, particularly affecting adolescents and young adults aged 15–25. High-risk HPV types pose significant risks, including cancers that impact physical, emotional, social, and financial well-being. Implementing a structured health promotion plan that combines education, vaccination, screening, counseling, and community engagement can effectively prevent HPV-related complications and improve quality of life. Aligning these strategies with Healthy People 2030 goals ensures evidence-based and equitable prevention.
References
Bailey, R. (2019). Goal setting and action planning for health behavior change. American Journal of Lifestyle Medicine, 13(6), 615–618. https://doi.org/10.1177/1559827617729634
Bastani, R., Glenn, B. A., Singhal, R., Crespi, C. M., Nonzee, N. J., Tsui, J., … Taylor, V. M. (2021). Increasing HPV vaccination among low-income, ethnic minority adolescents: Effects of a multicomponent system intervention through a county health department hotline. Cancer Epidemiology Biomarkers & Prevention, 31(1), 175–182. https://doi.org/10.1158/1055-9965.epi-20-1578
Chadwick, V., Bennett, K. F., McCaffery, K. J., Brotherton, J. M. L., & Dodd, R. H. (2022). Psychosocial impact of testing human papillomavirus positive in Australia’s human papillomavirus‐based cervical screening program: A cross‐sectional survey. Psycho-Oncology, 31(7), 1110–1119. https://doi.org/10.1002/pon.5897
Chesson, H. W., Laprise, J.-F., Brisson, M., Martin, D., Ekwueme, D. U., & Markowitz, L. E. (2021). The estimated lifetime medical cost of diseases attributable to human papillomavirus infections acquired in 2018. Sexually Transmitted Diseases. https://doi.org/10.1097/olq.0000000000001379
Clarke, M. A., Risley, C., Stewart, M. W., Geisinger, K. R., Hiser, L. M., Morgan, J. C., … Wentzensen, N. (2021). Age-specific prevalence of human papillomavirus and abnormal cytology at baseline in a diverse statewide prospective cohort. Cancer Medicine, 10(23), 8641–8650. https://doi.org/10.1002/cam4.4340
El-Zein, M., Coutlée, F., Tellier, P.-P., Roger, M., Franco, E. L., & Burchell, A. N. (2019). Human papillomavirus infection and transmission among couples through heterosexual activity (HITCH) cohort study: Protocol. JMIR Research Protocols, 8(1), e11284. https://doi.org/10.2196/11284
Hirth, J. M., Kuo, Y.-F., Starkey, J. M., Rupp, R. E., Laz, T. H., Rahman, M., & Berenson, A. B. (2019). Regional variations in human papillomavirus prevalence across time in NHANES (2003–2014). Vaccine, 37(30), 4040–4046. https://doi.org/10.1016/j.vaccine.2019.06.001
HPV. (2023, March). National Foundation for Infectious Diseases. https://www.nfid.org/infectious-disease/hpv/
Kombe, A. J., Li, B., Zahid, A., Mengist, H. M., Bounda, G.-A., Zhou, Y., & Jin, T. (2021). Epidemiology and burden of human papillomavirus and related diseases. Frontiers in Public Health, 8, 552028. https://doi.org/10.3389/fpubh.2020.552028
NURS FPX 4060 Assessment 4 Health Promotion Plan Presentation
Luttjeboer, J., Simons, J. J. M., Westra, T. A., Wilschut, J., Boersma, C., Postma, M. J., & van. (2023). An updated analysis of the impact of HPV vaccination based on long-term effectiveness in the Netherlands. Infectious Diseases and Therapy, 12(8), 2135–2145. https://doi.org/10.1007/s40121-023-00851-9
Rodríguez, L., Barrios, M., Pachón, C., & Lugo, E. (2019). Educational intervention on human papillomavirus in university students. Indian Journal of Community Medicine, 44(3), 213. https://doi.org/10.4103/ijcm.ijcm_247_18
Santos, P. D., Melly, P., Hilfiker, R., Giacomino, K., Perruchoud, E., Verloo, H., & Pereira, F. (2022). Effectiveness of educational interventions to increase skills in evidence-based practice among nurses: The EDITCare systematic review. Healthcare (Basel), 10(11), 2204. https://doi.org/10.3390/healthcare10112204
Soheili, M., Keyvani, H., Soheili, M., & Nasseri, S. (2021). Human papillomavirus: A review study of epidemiology, carcinogenesis, diagnostic methods, and treatment. Medical Journal of the Islamic Republic of Iran. https://doi.org/10.47176/mjiri.35.65
Sundaram, N., Voo, T. C., & Tam, C. C. (2019). Adolescent HPV vaccination: Empowerment, equity, and ethics. Human Vaccines & Immunotherapeutics, 16(8), 1835–1840. https://doi.org/10.1080/21645515.2019.1697596
U.S. Department of Health and Human Services. (2023). Healthy People 2030. https://health.gov/healthypeople
Vorsters, A., Bosch, F. X., Poljak, M., Waheed, D.-N., Stanley, M., & Garland, S. M. (2022). HPV prevention and control – The way forward. Preventive Medicine, 156, 106960. https://doi.org/10.1016/j.ypmed.2022.106960
NURS FPX 4060 Assessment 4 Health Promotion Plan Presentation
WHO. (2023, November 17). Cervical cancer. https://www.who.int/news-room/fact-sheets/detail/cervical-cancer
Yu, S., Zhu, Y., He, H., Hu, Y., Zhu, X., Diao, W., Li, S., Shan, G., & Chen, X. (2023). Prevalence and risk factors of oral human papillomavirus infection among healthy adults in Hebei, China. BMC Infectious Diseases, 23(1), 773. https://doi.org/10.1186/s12879-023-08759-y